MINNEAPOLIS, July 02, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the Company or Panbela), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced the…
PANBELA THERAPEUTICS ANNOUNCES CLOSING OF $10.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK
Share this article
More News
Another crypto company to sell its Bitcoin stash
July 25, 2026
Vietnam sets penalties under new crypto market rules
July 25, 2026
Hoskinson Discusses Crypto Market Outlook
July 25, 2026